Displaying drugs 14726 - 14750 of 15162 in total
CRx-401
CRx-401 is a novel insulin sensitizer designed to provide anti-diabetic activity without promoting weight gain. It consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate, an anti-cholesterol agent. In third-party clinical studies, the dose of bezafibrate contained in CRx-401 has been...
Investigational
Matched Description: … lipid profiles, and this dose has proven to be well tolerated in clinical trials. ... in CRx-401 has been observed to have a positive impact on cellular pathways that influence glycemic and …
Alphamethadol
Experimental
Illicit
4-Flourobenzenesulfonamide
Experimental
AL5424
Experimental
3-Amino-4-Oxybenzyl-2-Butanone
Experimental
Phenylacetaldehyde
Experimental
AL7089A
Experimental
Benzylamine
Experimental
4-(Hydroxymethyl)Benzamidine
Experimental
1,3-Dinitrobenzene
Experimental
Para-Bromobenzyl Alcohol
Experimental
DAS869
Experimental
4-Fluorobenzylamine
Experimental
2,6-Difluorobenzenesulfonamide
Experimental
1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea
Experimental
3-Iodo-Benzyl Alcohol
Experimental
3,3',5,5'-tetrachlorobiphenyl-4,4'-diol
Experimental
4-(trifluoromethyl)phenol
Experimental
2-Iodobenzylthio Group
Experimental
N-phenylthiourea
Experimental
AL6528
Experimental
Displaying drugs 14726 - 14750 of 15162 in total